Skip to search formSkip to main contentSkip to account menu

4-anilidopiperidine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
The steady appearance of new fentanyl analogues and the associated overdose deaths require the development of sensitive screening… 
Highly Cited
2012
Highly Cited
2012
SummarySynopsisFentanyl is a synthetic opioid with short-acting analgesic activity after intravenous or subcutaneous… 
Review
2006
Review
2006
Remifentanil (Ultiva), a 4-anilidopiperidine derivative of fentanyl, is an ultra-short-acting micro-opioid receptor agonist… 
Review
2004
Review
2004
1998
1998
Fentanyl, and its structural analogs lofentanil and sufentanil, are potent analgesics used clinically in the management of pain… 
Review
1995
Review
1995
  • T. Egan
  • Clinical Pharmacokinetics
  • 1995
  • Corpus ID: 46733797
SummaryRemifentanil is a novel, short-acting μ-receptor opioid agonist currently in the late stages of development. A member of… 
Review
1991
Review
1991
The findings reviewed herein have been the results of a five-year project undertaken by Anaquest to discover new therapeutically… 
Highly Cited
1991
Highly Cited
1991
In an effort to discover a potent ultrashort-acting mu opioid analgetic that is capable of metabolizing to an inactive species… 
1979
1979
Relatively little information is available concerning the influence of conformational factors on the potent analgesic actions of… 
1973
1973
Abstract: In view of the potency-enhancing effect of methyl substitution of the piperidine ring of the 4-phenylpiperidine…